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Abstract
Chlamydia trachomatis is responsible for both trachoma and sexually transmitted infections
causing substantial morbidity and economic cost globally. Despite this, our knowledge of its
population and evolutionary genetics is limited. Here we present a detailed whole genome
phylogeny from representative strains of both trachoma and lymphogranuloma venereum (LGV)
biovars from temporally and geographically diverse sources. Our analysis demonstrates that
predicting phylogenetic structure using the ompA gene, traditionally used to classify Chlamydia,
is misleading because extensive recombination in this region masks true relationships. We show
that in many instances ompA is a chimera that can be exchanged in part or whole, both within and
between biovars. We also provide evidence for exchange of, and recombination within, the cryptic
plasmid, another important diagnostic target. We have used our phylogenetic framework to show
how genetic exchange has manifested itself in ocular, urogenital and LGV C. trachomatis strains,
including the epidemic LGV serotype L2b.
INTRODUCTION
C. trachomatis is the most prevalent bacterial sexually transmitted infection (STI) world-
wide, with an estimated 101.5 million new cases among adults in 20051. Additionally,
ocular C. trachomatis is the leading infectious cause of blindness, with >40 million people
estimated to be suffering from active disease2.
C. trachomatis comprises two biovars: the trachoma biovar includes ocular and urogenital
strains characterized by localised infections of the epithelial surface of the conjunctiva or
genital mucosa; strains of the LGV biovar are distinguished by their ability to spread
systemically thorough the lymphatic system, causing genital ulceration and bubonic
disease3. LGV is reported most frequently in Africa, South East Asia, South America and
the Caribbean, while being rare in developed countries4-6. However, an ‘epidemic’ of LGV
exhibiting atypical presentation and symptoms is currently in progress in Europe and North
America, primarily affecting men who have sex with men (MSM).
Despite the obvious importance of C. trachomatis as a human pathogen, very little is known
about the evolution of strains causing disease7. This is primarily because modern diagnosis
is generally based on commercial nucleic acid amplification tests (NAATs)8,9 rather than
culture, where strains would be available for further study. Most of our understanding of the
diversity of circulating C. trachomatis is based on the primary surface antigen, the major
outer membrane protein (MOMP) and its gene, ompA. Typing has traditionally been
performed serologically using a number of antibodies against divergent epitopes within
MOMP, but has more recently switched to a genotyping approach using the ompA sequence.
Based on these methods, the two C. trachomatis biovars have been subdivided into 15-19
serotypes: the trachoma biovar includes ocular serotypes A to C and urogenital serotypes D
to K, while the LGV biovar includes serotypes L1, L2, L3 and L2b, the serotype associated
with the current LGV outbreak in Europe and North America. Although ompA genotyping
provides some further differentiation within these serotypes, it provides little or no detailed
information about the nature of the infecting strain or the variation in the remaining 99.88%
of the genome.
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Attempts have been made to reconstruct the C. trachomatis species phylogeny using ompA
sequences10, 16S rRNA gene analysis11, multilocus sequence typing (MLST)
approaches12-15 and whole genome sequencing16-18. However, there is still no consensus
over the true evolutionary relationships between C. trachomatis strains. It is generally
accepted that ompA does not reflect the phylogeny of the species14,19,20, but the lack of
agreement between trees produced from other small gene sets suggests that many other
regions of the C. trachomatis genome also provide conflicting phylogenetic evidence19.
Historically, horizontal gene transfer in the chlamydiae was considered unlikely due to their
obligate intracellular niche and because co-infection, and therefore opportunities for
recombination, are rare. Together these factors were thought to represent a barrier for
effective recombination. However, it has recently become evident that not only do the
chlamydiae have all the necessary recombination machinery21, they can recombine
following mixed infection both in tissue culture and the human host17. It is likely that this
recombination is the cause of the difficulty in resolving the relationships of C. trachomatis
strains.
Recent attempts to quantify the impact of recombination by reanalysing published genomes
have been limited by the small number available18. We set out to sample widely from the
diversity of clinical strains, and present 36 new C. trachomatis whole genome sequences.
Using these sequences and those previously published, we provide a detailed reconstruction
of the evolutionary history of C. trachomatis that identifies and takes into account the effect
of recombination. We show conclusively that the epidemic outbreak of L2b strains in
Europe was the result of clonal expansion and transmission, and provide evidence of
recombination in natural clinical strains both within and between biovars. We show the
impact that recombination has had on our general understanding of C. trachomatis diversity,
its implications for monitoring and epidemiological tracking of infections based on current
typing techniques, and provide evidence for the first time of recent serotype switches within
circulating clinical strains.
RESULTS
We sequenced 36 C. trachomatis genomes from global collections, isolated between 1959
and 2009, comprising 18 LGV, 14 urogenital and 4 ocular strains. Included are 12 L2b
strains, which originate from the UK, France, Sweden, the Netherlands and Canada, and a
further 6 LGV strains from South Africa and the USA, including historical L1 and L3
strains. The newly sequenced ocular strains are from Tanzania in 2000. Urogenital strains
were collected in the UK (10 strains), Sweden (3) and the USA (1). To guard against
potential cross contamination of strains and provide an independently verifiable set of
reference genomes, a key element of our experimental design was to use live strains that
were cultured individually. All strains are held as stocks except for three ocular strains that
were destroyed after culture. Our analysis also includes 16 previously published genome
sequences: 2 LGV (UK, USA), 3 ocular (Egypt, Tanzania and The Gambia) and 11
urogenital strains (USA, Sweden and not described), making a total of 52 strains included in
this study (see Supplementary Table 1).
Whole-genome phylogeny of C. trachomatis
To establish whether the current understanding of C. trachomatis phylogeny is
evolutionarily robust, we determined the interrelationships of our strain collection using
genome-wide single nucleotide polymorphisms (SNPs). To mitigate the effect of
homologous recombination between C. trachomatis strains on our phylogenetic
reconstruction, we employed the method of Croucher et al.22. The resulting tree (Fig. 1a, see
Fig. 1b for plasmid phylogeny, Supplementary Fig. 1 for bootstrap support values and
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Supplementary Fig. 2 for trees without recombination removed) provides compelling
evidence that ompA serotyping (Supplementary Fig. 3a) does not reflect the evolutionary
structure of C. trachomatis, with trachoma serotypes A, B, D, F, G and LGV serotype L1 all
occurring in multiple distinct branches on the tree. This clearly demonstrates that exchange
of the whole or part of the ompA gene is a natural phenomenon in distinct lineages of C.
trachomatis. Comparison of the whole-genome phylogeny with those reconstructed using
some of the available C. trachomatis MLST schemes (Supplementary Fig. 3b-d)
demonstrates that multi-locus techniques based on housekeeping loci show greater
congruency with our tree than the ompA phylogeny, but lack resolution.
The whole genome tree confirms that the species is split into two distinct clades representing
the trachoma and LGV biovars, separated by 4,860 SNPs. Using Chlamydia muridarum
NIGG as an outgroup, the root of the tree falls on the branch between the two biovars
(Supplementary Fig. 1), suggesting that this split occurred early in the evolutionary history
of the species, consistent with the conclusions of previous analyses based on 16S rRNA
gene sequences23.
The trachoma clade comprises two lineages (Fig. 1a T1 and T2) separated from their
common ancestor by 2,374 and 2,228 SNPs, respectively. T1 is composed of clinically
prevalent urogenital serotypes, while T2 contains most of the rarer urogenital serotypes24.
All ocular strains form a cluster within T2, indicating that they emerged from a urogenital
ancestor (Fig. 1a).
Strains within the LGV clade exhibit a far lower level of diversity than those in the trachoma
lineage, illustrated by the shorter branch lengths in Figure 1a. The 13 strains from the recent
L2b outbreak form a tight cluster with maximal bootstrap support (Supplementary Fig. 1).
The maximum pairwise evolutionary distance between the most variant strains within the
L2b serotype is just 19 SNPs. This low level of variation between the strains despite their
global distribution shows conclusively that the L2b epidemic25 is a clonal outbreak that has
spread throughout the world.
Our LGV collection also includes two South African strains (L1/115 and L1/224) that could
not originally be classified using micro-immunofluorescence with monoclonal antibodies
specific to the known MOMP types26. Sequence analysis of the ompA gene in these strains
showed that the 5′ end (variable segments VS1-2) matched the L1 ompA sequence, while
the 3′ end (VS3-4) matched L226. In our analysis, these strains form a clade midway
between an L1+L3 clade and a group including the L2 and L2b strains. A third South
African strain (L1/1322/p2), despite being genotyped as L1, is located on its own branch
distinct from the other L1 strain in this study (L1/440/LN). It is evident that these three
strains collected in South Africa define two new LGV lineages that are equally distinct as
the accepted LGV serotype clusters. This suggests that LGV diversity is far greater than
previously recognized, and that additional sampling is necessary.
Recombination is a natural phenomenon occurring widely within C. trachomatis strains
Considering the traditional view that Chlamydia do not recombine, we would expect that,
given the low level of variation identified relative to the size of the genome, very few
identical SNPs would have occurred multiple times independently on different branches of
the tree (homoplasies). However, superimposing the SNP events on the rooted phylogenic
tree using PAML27 shows that homoplasy is commonplace. Of the 17,163 sites in the
genome that exhibit a SNP in at least one strain (variant sites), 4,492 (26%) are homoplasic.
Homoplasic SNPs can arise by chance, as a result of a selective pressure for a particular
SNP to become fixed in a population, or by homologous recombination between divergent
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strains where sets of SNPs are effectively imported in one block. In cases where
recombination is the cause of homoplasy, it is expected that homoplasic SNPs shared by two
distant strains would be clustered along the genome sequence within the regions that have
been recombined. Therefore, dense clusters of compatible homoplasies are often used as
markers of recombination events. A pair of sites are incompatible if no tree can be drawn
upon which both sites could be reconstructed without at least one being homoplasic28. We
applied three compatibility-based recombination detection methods implemented in the
PhiPack package29: maximum χ230, neighbor similarity score (NSS)31 and the pairwise
homoplasy index (PHI)29 to these data. All three methods reported significant p-values (<<
0.05), indicating that compatibility is significantly higher between closely linked sites, as
would be expected if recombination had occurred, but not consistent with random
accumulation of homoplasies or convergent selection.
To investigate the recombination history, for each node on the tree we reconstructed the
ancestral DNA sequence using PAML27, and used a scanning statistic22 to identify regions
of the genome for which the node sequence was significantly more similar to a distant
branch on the tree than to its direct ancestral node (see methods). Figure 2 shows a
reconstruction of recombination events across the C. trachomatis tree, where the location of
the recombination in the genome of the recipient branch is shown, and colors illustrate the
phylogenetic position of the most likely donor. In total, 267 putative recombination blocks
ranging from 3 to 50,141bp (mean = 4039bp) were reconstructed, covering 539,409bp
(51%) of the aligned genome length. This provides strong evidence that recombination has
occurred many times during the evolution of the species and has not only happened at a few
limited ‘hotspots’ as reported in previous papers18,32, but across a large proportion of the
genome. SNP density along the length of the genome is not constant, however. Some
regions do show increased SNP and homoplasy density, which may be the result of
diversifying selection within the species or homologous recombination importing pre-
selected SNPs from outside of the species. Of particular note are six regions of the genome
in which SNP density, homoplasy density and recombination density are all significantly
raised (Fig. 2). These are in ompA (region 1), region 2 encoding the polymorphic outer
membrane proteins, and region 3 predicted to encode four hypothetical proteins (CTL304-
CTL307) and the 3′ end of hemN. Recombination density is also raised around region 4,
encoding a putative membrane protein (CTL0399), region 5 spanning the plasticity zone and
region 6 carrying genes predicted to encode a conserved hypothetical protein (CTL0886), a
putative exported protein (CTL0887) and a putative virulence protein (mviN). Four of these
regions (1-3 and 6) also show raised levels of non-homoplasic SNPs, which may be the
result of further recombinations from lineages not represented on our tree.
Evidence of recombination within and between biovars
Within the LGV clade, 5% (46) of the 920 variant sites are homoplasic. Twelve
recombinations were reconstructed within the clade, all of which are between different LGV
serotypes (Supplementary Fig. 4) and six of which coincide with regions of the genome that
were also found to recombine in other C. trachomatis lineages (Fig. 2; regions 1, 2 and 3).
Three recombinations were identified as affecting ompA, and can be interpreted by
visualizing the SNP distribution as a genetic ‘barcode’ (Fig. 3). A region of almost 3kb,
from the 3′ end of the gene encoding the translation elongation factor, tsf, through the 3′
end of ompA to VS2 (Fig. 3) appears to have been replaced by homologous recombination
between L1/440/LN and L1/1322/p2, explaining why these two strains, which are distinct on
the tree, are both typed as L1. A second recombination of only 25bp in the VS2 region of
ompA was identified as an exchange between the L2 and L2b clades (Fig. 3), explaining the
reported serotypic results, as the two South African strains, typed as L1/L2 hybrids based on
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sequence (L1/115 and L1/224, Fig. 3), differ from the archetypal L2 sequence in this region.
The third recombination is also located in VS2, between L1/404/LN and the L2 clade.
More surprisingly, there is clear evidence of recombination between the LGV and trachoma
biovars, with 24 events reconstructed. 14 of these affect the ompA gene, with a particularly
clear example being the similarity of the L3 ompA sequence to that of trachoma serotypes
Ia, J and K (Fig. 3), which was noted when the K serotype was first recognized33. Outside
ompA, the clearest inter-biovar recombination is a region of 665bp within the recD gene in
which 47 SNPs have been transferred from the T2 trachoma lineage to the two African
LGVs, L1/115 and L1/224 (Supplementary Fig. 5).
Within the trachoma biovar, recombination events are far more prevalent. 3,367 (26.2%) of
the 15,902 variant sites exhibit homoplasy, and 162 intra-biovar recombination events were
reconstructed (Fig. 2), covering 446,917bp (43%) of the length of the aligned genomes.
Figure 3 highlights the extent of ompA swapping between trachoma strains. Not only have
multiple serotype switches occurred, but the SNP barcodes of the ompA gene show clearly
that serotypes with similar barcodes (sequences) do not necessarily fall near each other on
the tree (Fig. 3). 43 recombination events were also reconstructed between ocular and
urogenital branches, clearly indicating that DNA exchange occurs between these two
biotypes (Fig. 2).
Evidence of recent recombination
Our analyses provide convincing evidence that recombination is an ongoing process rather
than a purely historical event in the evolution of C. trachomatis. This can be clearly
illustrated with two examples.
Seth-Smith et al.16 described the genome of a serotype B strain (B/TZ1A828/OT) from
Kongwa, central Tanzania. In this study we have included new genomes from four serotype
A strains (A/2497, A/363, A/5291 and A/7249) from Rombo, Northern Tanzania, 550km
from Kongwa. Our phylogenetic reconstruction placed these new strains as the sister group
to B/TZ1A828/OT rather than the reference serotype A strain, A/HAR-13. Analysis of the
SNP differences between the genomes of B/TZ1A828/OT and a representative (A/2497) of
the new serotype A strains (Supplementary Fig. 6a) shows that 434 of the 720 SNPs
differentiating them are located in a 10kb region (4.34% divergence) around ompA (from
aspC to pbpB) (Supplementary Fig. 6b), such that the ompA genes are highly divergent, yet
the remaining 99% of the genome differs at only 286 nucleotide sites (0.027% divergence).
The converse is true if the reference A/HAR-13 is compared with A/2497. In this
comparison there are 1,242 SNP differences, with only 170 found in the same 10kb region in
and around ompA, and 1,072 in the remainder of the genome (Supplementary Fig. 6a-b).
Closer inspection shows that the ompA gene itself is almost identical between the genomes
of A/2497 and A/HAR-13 (differing by 5 SNPs), while the ompA sequence of B/TZ1A828/
OT is highly divergent (199 SNPs) (Supplementary Fig. 6c), explaining why the four new
strains are serotype A. This is clear evidence for a recent recombination event where a
divergent ompA gene has replaced the existing ompA sequence and changed the serotype of
the circulating clone. Although it is difficult to be certain of the direction of the change:
from serotype A to B or vice-versa, this example underlines the need to use genome-wide
SNPs to be confident of the phylogenetic history of Chlamydia strains.
We also see evidence for a recent recombination event within the new-variant (nvCT)
Swedish serotype E strain (E/SW2)34. Comparison with another Swedish serotype E strain
(E/SW3) shows close similarity along most of the genome length, excepting a large number
of SNPs in a 30kb region spanning CTL393 to CTL417 (Supplementary Fig. 6d). The
sequence of this region in E/SW2 exactly matches the homologous region in D/UW3/CX
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(Supplementary Fig. 6d), indicating a recombination event in E/SW2 from a D/UW3/CX-
like donor. The exchanged genes are of unknown function and phenotypic comparison of
nvCT to other serotype E strains has identified no differences35.
Plasmid phylogeny and recombination
Previously16 we showed that the cryptic plasmids of a small sample of C. trachomatis strains
share the same evolutionary history as their chromosomes, suggesting that the plasmid is not
(or rarely) exchanged. Analyzing our much larger dataset of 43 plasmids for evidence of
recombination and exchange showed a single difference in phylogenetic structure between
the chromosomal and plasmid trees (Fig. 1) relating to two serotype Ia strains from
Southampton, UK. In the whole genome analysis, these two strains group in the T2 cluster,
while in the plasmid phylogeny they form a distinct branch between the T1 and T2 clades
(Fig. 1b). Reconstructing SNP events across the plasmid tree shows that the SNPs
supporting the positioning of these Ia strains are distributed along the length of the plasmid
sequence (Supplementary Fig. 7): this is evidence of replacement of the Ia lineage plasmid
with an equivalent plasmid, potentially from an unsampled C. trachomatis lineage. All other
relationships are congruent between the plasmid and chromosome trees, suggesting that
exchange of whole plasmids between distant C. trachomatis strains is indeed rare. We
identified just 7 homoplasies on the plasmid tree (Supplementary Fig. 7). Applying the
methods for recombination detection detailed above, we identified a single recombination
event that accounted for 6 of these homoplasies (Supplementary Fig. 7). The recombination
region extends from the middle of pCDS3 to the middle of pCDS5 and can be best explained
by homologous recombination of this region between the ocular strains and the T1 clade. By
reconstructing phylogenies of the recombination region and the rest of the plasmid it can be
seen that the recombined region in the ocular strains clusters in the T1 clade rather than T2
(Supplementary Fig. 8). Alternative explanations would be recombination between the Ia
plasmid and the T2 clade, or that the Ia plasmid is a chimera between an T2 plasmid and an
unknown donor plasmid. We think the latter is unlikely, as the Ia plasmid does not cluster
within a T2 clade in either the backbone or recombined regions.
A further interesting discovery is a previously unrecognized deletion in the plasmid of LGV
strain pL3/404/LN within pCDS1 (Supplementary Fig. 7) in a different location to that of
the nvCT, providing further evidence that pCDS1 is not a stable diagnostic target.
DISCUSSION
In the past, studies of the evolutionary history and diversity of C. trachomatis have almost
always been based on serological classification or the sequence of a small number of genes.
We have shown that these loci do not necessarily represent the true history of the species, or
the true relationships between strains, and that an in-depth understanding of the population
structure of the chlamydia requires the maximum resolution available: whole genome data.
This resolution has allowed us to observe the extent of recombination that has occurred in
the population and raises a number of issues of clinical significance.
Our analysis has confirmed that C. trachomatis comprises three distinct lineages. The
species appears to have split early into LGV and urogenital clades, with the urogenital clade
itself later splitting into two clades termed T1 and T2. Ocular Chlamydia is a younger
lineage that, within the limits of our sampling frame, appears to have emerged only once
from a urogenital ancestor within T2, although more data are needed to confirm this
observation. Within the LGV biovar, the emergence of the ‘epidemic’ L2b is a clonal
expansion that probably resulted from a single introduction into Europe or North America.
We suggest that the lack of variation seen within the L2b genomes is indicative of relatively
rapid transmission (rather than a lower rate of recombination) as exemplified by the
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emergence and spread of the Swedish nvCT, which evaded detection by some NAATs due
to a deletion in the first coding sequence (CDS) of the plasmid. The nvCT and L2b
outbreaks have shown that given a selective advantage or lack of competition, a single
lineage of C. trachomatis can proliferate and spread. However, for lineages with more subtle
changes occurring outside either ompA or diagnostic primer binding sites,such as drug
resistance, it would be more difficult to detect such a clonal expansion using current
diagnostic and molecular typing techniques. Fortunately, until now there have been only
sporadic reports of antibiotic resistance in clinical strains36-39 despite the fact that it is
possible to induce resistance in the laboratory40.
Although recombination in C. trachomatis was once a controversial concept it has more
recently been shown to occur both in laboratory tissue culture17 and naturally between
clinical strains17,20,32,41,42. We have extended these observations by demonstrating that
recombination is not limited to a few ‘hotspots’ around the chromosome. Rather than true
hotspots, it is likely that previous studies18,32 have simply observed higher rates of fixation
of recombinations in genomic regions that are under diversifying selection pressure.
In contrast to a previous analysis18, our more comprehensive assessment of C. trachomatis
diversity shows greater exchange between strains with tropism for the same site or tissue,
which correlates with the majority of reports of mixed infections43-47. However, we have
identified multiple examples of recombination between strains with tropisms for different
tissues, and even between biovars, suggesting that there are no absolute barriers to genetic
exchange. In particular, recombination between ocular and urogenital strains appears
relatively frequent, again correlating with reports of both cross-site and mixed infections of
ocular and urogenital serotypes47-50.
The clinical significance of our findings is extensive. We have shown clear examples in
which the genetic backbone of the strain is unlinked from its serotype.
Replacement and chimaerism of ompA is most likely a process of diversification that
counteracts the effect of the immune system protecting the host against immediate
reinfection, and as such it is clear that the ompA gene, the main chromosomal diagnostic
target used to detect C. trachomatis infections and to type strains, is a poor indicator of
genetic relatedness within the species. This may explain why there are equally as many
studies that have failed to draw significant association between disease severity and the
nature of the infecting strain51-55 as those that have found an association44,56-59.
Multi-locus typing schemes, particularly those based on housekeeping genes under low
selective pressure, more closely reflect the genome phylogeny, and may prove useful in
cases where the ultimate resolution of genome-wide SNP-based techniques is not necessary.
However, any scheme based on a small number of loci has the potential to be confused by
recombination, so that different MLST schemes will differ in resolution and accuracy
(Supplementary Fig. 3b-d). The choice of typing approach will need to be determined on a
case-by-case basis depending on the resolution required to answer the question at hand.
Finally, we have shown for the first time that there has been some exchange of, and
homologous recombination within, the DNA of the cryptic plasmid, providing further
evidence of the potential unreliability of the plasmid for diagnostics and typing.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Appendix
ONLINE METHODS
Cell culture, DNA extraction and sequencing
The strains and sources of C. trachomatis used in this work are summarized in
Supplementary Table 1. Cell culture and DNA extraction was performed as Seth-Smith et
al.16 for all strains except A/363, A/5291 and A/7249, which were extracted from a single 24
well plate using 1N NaOH followed by neutralization with Tris. The genome of A/2497 was
sequenced to a depth of 12x coverage derived from pUC18 (insert size 0.7 kb) small insert
libraries using dye terminator chemistry on ABI3700 automated sequencers. End sequences
from larger insert plasmid (pMAQ1 9-12 kb insert size) libraries were used as a scaffold.
Sequencing, assembly, finishing and checking of this genome was as described60. The
genome sequence of strain L2b/UCH-1 was improved with Illumina GAII data, 2,877,472
37bp paired end reads using iCORN61. All other genomes were sequenced using Illumina
Genome Analyzer (Illumina) as summarized in Supplementary Table 1. Additionally, PCRs
were performed on genomic DNA to confirm the sequences of the repetitive regions within
hctB, tarp and at the plasmid origin using Platinum Pfx (Invitrogen), an annealing
temperature of 60°C using primers HC2_f, HC2_r, tarp_f, tarp_r, pori_f and pori_f (see
Supplementary Table 2). PCR products were sequenced using the primers above plus
primers tarp_s1-tarp_s7 (see Supplementary Table 2).
Assembly and Alignment
Illumina reads were assembled using velvet v1.0.1262. Due to the small size and non-
repetitive nature of the C. trachomatis genome, most assemblies produced only a small
number of contigs that could be scaffolded by hand using the genome of L2/434/BU63 as a
reference (acc no AM884176), with the circular genome cut at the origin immediately
upstream of hemB. Manual insertion of hctB and tarp gene sequences resulted in Improved
High Quality Draft Sequences64 made up of 1-11 contigs (Supplementary Table 1). Plasmid
assemblies were completed by PCR across the origin to give a single contig. To double-
check the assemblies and ensure than none of our cultures were mixed populations, raw data
was mapped back against the assemblies using SMALT (see URLs) to check for
heterozygosity. All genome and plasmid sequences have been deposited at EMBL under
accession numbers given in Supplementary Table 1. Complete genomes were aligned with
progressiveMauve65 using the --collinear option. The resulting alignment was manually
checked and misalignments improved.
In order to allow the phylogenetic tree to be rooted, the sequence of Chlamydia muridarum
Nigg (AE002160.2) was added to the alignment. Due to the divergent nature of this
sequence, it was not possible to align it to the rest of the sequences with progressiveMauve.
Instead, it was fragmented in silico and then mapped to the C. trachomatis alignment using
SMALT.
Phylogenetic reconstruction
Due to limitations of assembly of repetitive regions using short-read data, repetitive regions
of the consensus of aligned genomes were identified using REPuter66 and excluded from
phylogenetic analysis. A phylogenetic reconstruction of the alignment data was carried out
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using RAxML v7.0.467 using a GTR model of evolution with a GAMMA correction for
among site rate variation with four rate categories. To reduce the effect of recombination on
the phylogeny, the iterative recombination removal method of Croucher et al.22 was
employed with 100 bootstrap replicates calculated on the final tree to provide a measure of
support for the relationships identified.
Ancestral sequence reconstruction and recombination detection
Ancestral sequences were reconstructed onto each node of the phylogeny using PAML27.
From these ancestral sequences, SNPs were reconstructed onto branches of the tree. To
identify recombination in the data we applied a moving window approach similar to that
used in Croucher et al.22. Croucher et al. identified regions of high SNP density on a given
branch of the Streptococcus pneumoniae PMEN1 phylogeny and hypothesized these to
represent recombination events from a source outside of the PMEN1 lineage. Here the same
principal was applied exclusively to homoplasic SNPs, in order to identify regions of
homologous replacement within the tree. First, homoplasic SNPs were identified for each
branch of the tree using the PAML reconstruction of ancestral sequences. The DNA
sequences on each branch (the potential recipient) were then compared, in turn, to the
corresponding bases along all other branches on the tree to identify potential donors. For all
pairwise comparisons where at least three shared homoplasies were found, a moving
window approach was used to identify regions where these occurred at a higher density than
would be expected if they were randomly acquired. The lengths of these regions were then
refined using a spatial scanning statistic as described in Croucher et al.22, which alters the
length of the region until the recombination likelihood is maximized. Once the likelihood of
all clusters was calculated for all recipient branches, SNPs produced by the cluster with the
highest likelihood were removed and the process repeated iteratively until no significant
homoplasy clusters were identified.
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Figure 1. Maximum likelihood reconstruction of the phylogeny of C. trachomatis with
recombinations removed
(a) C. trachomatis species phylogeny using the chromosomal sequences of 52 genomes after
predicted recombinations have been removed using the method described in Croucher et
al.22. Bootstrap support for nodes on the tree are shown in Supplementary Figure 1. (b)
Phylogenetic reconstruction of the C. trachomatis plasmid after predicted recombinations
have been removed. Strain names are colored by serotype, see key. Scale bar represents
number of SNPs. Plasmid sequences were not available for all strains in a. For comparison,
trees without recombination removal are shown in Supplementary Figure 2.
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Figure 2. Reconstruction of recombination events on the species phylogeny of C. trachomatis
The top line represents the full chromosome structure of C. trachomatis based on L2/434/
BU, with CDSs represented as blue boxes on the relevant coding strand. Numbers indicate
position in the genome alignment, beginning at CTL0001 (L2/434/BU accession number
AM884176). Each horizontal track represents the chromosome of a strain in the species
phylogeny on the left. Blocks shown on the tracks represent the location of received
homologous replacements, with their color corresponding to the color of the donor branch
on the tree. Tree branches and taxon names are colored by phylogenetic distance, with more
similar colors representing more closely related branches. Regions of interest along the
genome are highlighted immediately below the recombination tracks. Below this are plots of
the density of non-homoplasic SNP sites, homoplasic SNP sites and recombination events,
based on a moving window analysis. Window size = 2000bp.
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Figure 3. Distribution of SNPs in the ompA gene of C. trachomatis
The top line represents the structure of the ompA gene, showing the location of variable
regions (VS1-4, red blocks) and cysteine residues (conserved in blue, non-conserved in
orange). On the left is the species phylogeny of C. trachomatis, with strain names colored by
serotype, see key. Adjacent to each strain name is a track with a background color based on
the serotype of the corresponding strain. Colored vertical lines along the tracks represent
bases that differ from the ancestral sequence: grey=non-homoplasic change; colored lines
represent homoplasic bases: red=A, blue=T, green=C, orange=G. The pattern of lines
provide a barcode of ompA similarity between strains.
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